UBS Group’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.39M | Sell |
|
|||||
|
2025
Q1 | $10.5M | Buy |
|
|||||
|
2024
Q4 | $12.4M | Buy |
|
|||||
|
2024
Q3 | $6.15M | Buy |
|
|||||
|
2024
Q2 | $3.35M | Sell |
|
|||||
|
2024
Q1 | $5.26M | Buy |
|
|||||
|
2023
Q4 | $4.67M | Buy |
|
|||||
|
2023
Q3 | $1.77M | Buy |
|
|||||
|
2023
Q2 | $269K | Sell |
|
|||||
|
2023
Q1 | $2.17M | Sell |
|
|||||
|
2022
Q4 | $4.87M | Buy |
|
|||||
|
2022
Q3 | $906K | Sell |
|
|||||
|
2022
Q2 | $1.57M | Sell |
|
|||||
|
2022
Q1 | $4.98M | Buy |
|
|||||
|
2021
Q4 | $3.72M | Buy |
|
|||||
|
2021
Q3 | $342K | Sell |
|
|||||
|
2021
Q2 | $346K | Buy |
|
|||||
|
2021
Q1 | $241K | Buy |
|
|||||
|
2020
Q4 | $153K | Sell |
|
|||||
|
2020
Q3 | $251K | Buy |
|
|||||
|
2020
Q2 | $178K | Sell |
|
|||||
|
2020
Q1 | $1.46M | Buy |
|
|||||
|
2019
Q4 | $619K | Sell |
|
|||||
|
2019
Q3 | $2.12M | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $40K | Sell |
|
|||||
|
2018
Q4 | $20K | Sell |
|
|||||
|
2018
Q3 | $49K | Sell |
|
|||||
|
2018
Q2 | $80K | Buy |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2017
Q4 | $11K | Buy |
|
|||||
|
2017
Q3 | $11K | Sell |
|
|||||
|
2017
Q2 | $22K | Buy |
|
|||||
|
2017
Q1 | $18K | Sell |
|
|||||
|
2016
Q4 | $33K | Buy |
|
|||||
|
2016
Q3 | $9K | Sell |
|
|||||
|
2016
Q2 | $23K | Buy |
|
|||||
|
2016
Q1 | $23K | Buy |
|
|||||
|
2015
Q4 | $21K | Buy |
|
|||||
|
2015
Q3 | $13K | Sell |
|
|||||
|
2015
Q2 | $34K | Buy |
|
|||||
|
2015
Q1 | $12K | Buy |
|
|||||
|
2014
Q4 | $7K | Buy |
|